Concepedia
Statistics
Publications
16
Citations
901
H-Index
15
Active since
1977
Affiliations
Churchill Hospital(Current)
University of Oxford
Cancer Research UK
Beatson West of Scotland Cancer Centre
Royal Marsden Hospital
D C Talbot is an author at Churchill Hospital specializing in medicine, oncology, and pharmacology.
Publications per year
1977–2011
PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER
Alexandra Giatromanolaki, Michael Koukourakis, Kenneth J. O’Byrne et al. · The Journal of Pathology · 1996 · 171 citations
Medicine, Oncology, Pathology +17
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
Valentine M. Macaulay, Kenneth J. O’Byrne, Mark Saunders et al. · PubMed · 1999 · 160 citations
Medicine, Oncology, Pharmacology +14
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.
N C Levitt, Ferry A.L.M. Eskens, Kenneth J. O’Byrne et al. · PubMed · 2001 · 136 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancer.
D C Talbot, Ian E. Smith, Janine Mansi et al. · Journal of Clinical Oncology · 1991 · 62 citations
Medicine, Oncology, Pharmacology +12
Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.
W.P. Steward, Dunlop Dj, G Dabouis et al. · PubMed · 1996 · 58 citations
Medicine, Oncology, Pharmacology +16
1–5 of 16